Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-01

Clinical Trial Update: Effect of Brivaracetam in Photosensitive Epileptic Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Brivaracetam in photosensitive epilepsy subjects has completed; the report summarizes the study's safety and exploratory efficacy findi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 2 | Status: COMPLETED